{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T22:05:16Z","timestamp":1760997916505,"version":"3.44.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T00:00:00Z","timestamp":1755475200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T00:00:00Z","timestamp":1755475200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e4tsklinikum Leipzig"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Etiology and pathogenesis of biliary atresia (BA) remain elusive. Evidence points to a T cell mediated autoimmune response contributing to the disease by driving the ongoing hepatic inflammation. CD26, also known as dipeptidylpeptidase 4 (DPP4), is an immunoregulatory protein also expressed on T-lymphocytes. We aimed to investigate the potential of pharmacological DPP4 inhibition on cytokine production of T cells and potential therapeutic benefits in experimental BA. We analyzed the expression and regulation of CD26\/DPP4 on \u03b1\u03b2 and \u03b3\u03b4 T cells in mice suffering from rotavirus-induced BA. Enzymatic DPP4 activity in murine and human serum was examined. In cell cultures, lymphocytes were incubated with the DPP4-inhibitor Sitagliptin to study the effects of DPP4 inhibition on cytokine production. Clinical effects were assessed by intraperitoneal Sitagliptin injection of mice suffering from BA. Analyses included flow cytometry, qPCR, serum analysis and histological examinations. In mice suffering from BA, CD26\/DPP4 was strongly expressed and upregulated on \u03b1\u03b2 and to an even greater extent on \u03b3\u03b4 T cells compared to healthy controls. DPP4-inhibition led to a dose-dependent suppression of the pro-inflammatory cytokines IL-17 and IFN-\u03b3 produced by Th1, Th17 and \u03b3\u03b4 T cells. Therapeutic administration of Sitagliptin in experimental BA led to reduced serum levels of GOT and Bilirubin as well as decreased hepatic infiltration with F4\/80<jats:sup>+<\/jats:sup> macrophages but had no effect on overall survival. In humans, serum DPP4-activity was upregulated in infants suffering from BA compared to healthy children. To our knowledge, this is the first time an upregulation of CD26 expression has been demonstrated for \u03b3\u03b4 T cells in the setting of an autoimmune inflammatory response. Mechanistically, we could demonstrate that DPP4\/CD26 is upregulated on T cells in experimental BA and that pharmacological inhibition decreased their pro-inflammatory potential. However, this translated to only mild clinical benefits in the mouse model. Thus, although the protein appears to play a role in BA, further research is needed to elucidate the potential to serve as a therapeutic target.<\/jats:p>","DOI":"10.1038\/s41598-025-16097-z","type":"journal-article","created":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T15:05:04Z","timestamp":1755529504000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["DPP4-inhibition reduces pro-inflammatory cytokine production by alpha-beta and gamma-delta T cells in vitro and in the biliary atresia mouse model"],"prefix":"10.1038","volume":"15","author":[{"given":"Anne-Christin","family":"Wilde","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie","family":"Uecker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faikah","family":"Gueler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Immo","family":"Prinz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Omid","family":"Madadi-Sanjani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claus","family":"Petersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joachim F.","family":"Kuebler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Klemann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,8,18]]},"reference":[{"issue":"2","key":"16097_CR1","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1055\/s-0030-1268476","volume":"21","author":"J Leonhardt","year":"2011","unstructured":"Leonhardt, J. et al. Biliary atresia: lessons learned from the voluntary German registry. Eur. J. Pediatr. Surg. Off J. Austrian Assoc. Pediatr. Surg. Al Z. Kinderchir. 21 (2), 82\u201387. https:\/\/doi.org\/10.1055\/s-0030-1268476 (2011).","journal-title":"Eur. J. Pediatr. Surg. Off J. Austrian Assoc. Pediatr. Surg. Al Z. Kinderchir"},{"issue":"9197","key":"16097_CR2","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/S0140-6736(99)03492-3","volume":"355","author":"PJ McKiernan","year":"2000","unstructured":"McKiernan, P. J., Baker, A. J. & Kelly, D. A. The frequency and outcome of biliary Atresia in the UK and Ireland. Lancet Lond. Engl. 355 (9197), 25\u201329. https:\/\/doi.org\/10.1016\/S0140-6736(99)03492-3 (2000).","journal-title":"Lancet Lond. Engl."},{"issue":"2","key":"16097_CR3","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1097\/MPG.0000000000000755","volume":"61","author":"AG Feldman","year":"2015","unstructured":"Feldman, A. G. & Mack, C. L. Biliary atresia: clinical lessons learned. J. Pediatr. Gastroenterol. Nutr. 61 (2), 167\u2013175. https:\/\/doi.org\/10.1097\/MPG.0000000000000755 (2015).","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"16097_CR4","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/1750-1172-8-128","volume":"8","author":"C Petersen","year":"2013","unstructured":"Petersen, C. & Davenport, M. Aetiology of biliary atresia: what is actually known? Orphanet J. Rare Dis. 8, 128. https:\/\/doi.org\/10.1186\/1750-1172-8-128 (2013).","journal-title":"Orphanet J. Rare Dis."},{"issue":"6","key":"16097_CR5","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1038\/nrgastro.2015.74","volume":"12","author":"A Asai","year":"2015","unstructured":"Asai, A., Miethke, A. & Bezerra, J. A. Pathogenesis of biliary atresia: defining biology to understand clinical phenotypes. Nat. Rev. Gastroenterol. Hepatol. 12 (6), 342\u2013352. https:\/\/doi.org\/10.1038\/nrgastro.2015.74 (2015).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"16097_CR6","doi-asserted-by":"publisher","first-page":"329","DOI":"10.3389\/fimmu.2020.00329","volume":"11","author":"A Ortiz-Perez","year":"2020","unstructured":"Ortiz-Perez, A. et al. Innate immunity and pathogenesis of biliary Atresia. Front. Immunol. 11, 329. https:\/\/doi.org\/10.3389\/fimmu.2020.00329 (2020).","journal-title":"Front. Immunol."},{"issue":"7","key":"16097_CR7","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1016\/j.cell.2020.10.048","volume":"183","author":"J Wang","year":"2020","unstructured":"Wang, J. et al. Liver immune profiling reveals pathogenesis and therapeutics for biliary Atresia. Cell 183 (7), 1867\u20131883e26. https:\/\/doi.org\/10.1016\/j.cell.2020.10.048 (2020).","journal-title":"Cell"},{"key":"16097_CR8","doi-asserted-by":"publisher","first-page":"279","DOI":"10.3389\/fped.2019.00279","volume":"7","author":"S Zhang","year":"2019","unstructured":"Zhang, S. et al. CD4\u2009+\u2009T cell subset profiling in biliary Atresia reveals ICOS\u2009\u2014regulatory T cells as a favorable prognostic factor. Front. Pediatr. 7, 279. https:\/\/doi.org\/10.3389\/fped.2019.00279 (2019).","journal-title":"Front. Pediatr."},{"key":"16097_CR9","doi-asserted-by":"publisher","unstructured":"Yang, Y. et al. Elevated Th17 cells accompanied by decreased regulatory T cells and cytokine environment in infants with biliary atresia. Pediatr Surg Int. 29(12), 1249\u20131260 (2013). https:\/\/doi.org\/10.1007\/s00383-013-3421-6","DOI":"10.1007\/s00383-013-3421-6"},{"issue":"1","key":"16097_CR10","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1186\/s12887-024-05152-9","volume":"24","author":"Z Ji","year":"2024","unstructured":"Ji, Z., Wu, X., Ren, H. & Feng, J. Mechanism of biliary Atresia caused by T follicular helper cells-induced immune injury. BMC Pediatr. 24 (1), 669. https:\/\/doi.org\/10.1186\/s12887-024-05152-9 (2024).","journal-title":"BMC Pediatr."},{"issue":"1","key":"16097_CR11","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1002\/hep.28851","volume":"65","author":"CS Lages","year":"2017","unstructured":"Lages, C. S. et al. The dendritic cell-T helper 17-macrophage axis controls cholangiocyte injury and disease progression in murine and human biliary Atresia. Hepatol. Baltim. Md. 65 (1), 174\u2013188. https:\/\/doi.org\/10.1002\/hep.28851 (2017).","journal-title":"Hepatol. Baltim. Md."},{"issue":"11","key":"16097_CR12","doi-asserted-by":"publisher","first-page":"e1070","DOI":"10.1002\/ctm2.1070","volume":"12","author":"C Ye","year":"2022","unstructured":"Ye, C. et al. Single-cell and Spatial transcriptomics reveal the fibrosis-related immune landscape of biliary Atresia. Clin. Transl Med. 12 (11), e1070. https:\/\/doi.org\/10.1002\/ctm2.1070 (2022).","journal-title":"Clin. Transl Med."},{"key":"16097_CR13","doi-asserted-by":"publisher","first-page":"786422","DOI":"10.3389\/fped.2021.786422","volume":"9","author":"J Zhang","year":"2021","unstructured":"Zhang, J., Luo, Y., Feng, M. & Xia, Q. Identification of liver immune microenvironment-related hub genes in liver of biliary Atresia. Front. Pediatr. 9, 786422. https:\/\/doi.org\/10.3389\/fped.2021.786422 (2021).","journal-title":"Front. Pediatr."},{"issue":"2","key":"16097_CR14","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/nri3384","volume":"13","author":"P Vantourout","year":"2013","unstructured":"Vantourout, P. & Hayday, A. Six-of-the-best: unique contributions of \u03b3\u03b4 T cells to immunology. Nat. Rev. Immunol. 13 (2), 88\u2013100. https:\/\/doi.org\/10.1038\/nri3384 (2013).","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"16097_CR15","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1053\/j.gastro.2015.09.008","volume":"150","author":"C Klemann","year":"2016","unstructured":"Klemann, C. et al. Interleukin 17, produced by \u03b3\u03b4 T cells, contributes to hepatic inflammation in a mouse model of biliary Atresia and is increased in livers of patients. Gastroenterology 150 (1), 229\u2013241e5. https:\/\/doi.org\/10.1053\/j.gastro.2015.09.008 (2016).","journal-title":"Gastroenterology"},{"issue":"12","key":"16097_CR16","doi-asserted-by":"publisher","first-page":"3031","DOI":"10.1111\/liv.14639","volume":"40","author":"N M\u00f6hn","year":"2020","unstructured":"M\u00f6hn, N. et al. Synthetic retinoid AM80 inhibits IL-17 production of gamma delta T cells and ameliorates biliary Atresia in mice. Liver Int. Off J. Int. Assoc. Study Liver. 40 (12), 3031\u20133041. https:\/\/doi.org\/10.1111\/liv.14639 (2020).","journal-title":"Liver Int. Off J. Int. Assoc. Study Liver"},{"issue":"3","key":"16097_CR17","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1080\/713609354","volume":"40","author":"AM Lambeir","year":"2003","unstructured":"Lambeir, A. M., Durinx, C., Scharp\u00e9, S. & De Meester, I. Dipeptidyl-peptidase IV from bench to bedside: an update on structural properties, functions, and clinical aspects of the enzyme DPP IV. Crit. Rev. Clin. Lab. Sci. 40 (3), 209\u2013294. https:\/\/doi.org\/10.1080\/713609354 (2003).","journal-title":"Crit. Rev. Clin. Lab. Sci."},{"issue":"1","key":"16097_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/cei.12781","volume":"185","author":"C Klemann","year":"2016","unstructured":"Klemann, C., Wagner, L., Stephan, M. & von H\u00f6rsten, S. Cut to the chase: a review of CD26\/dipeptidyl peptidase-4\u2019s (DPP4) entanglement in the immune system. Clin. Exp. Immunol. 185 (1), 1\u201321. https:\/\/doi.org\/10.1111\/cei.12781 (2016).","journal-title":"Clin. Exp. Immunol."},{"issue":"12","key":"16097_CR19","doi-asserted-by":"publisher","first-page":"e2250302","DOI":"10.1002\/eji.202250302","volume":"53","author":"M Drakul","year":"2023","unstructured":"Drakul, M. & \u010coli\u0107, M. Immunomodulatory activity of dipeptidyl peptidase-4 inhibitors in immune-related diseases. Eur. J. Immunol. 53 (12), e2250302. https:\/\/doi.org\/10.1002\/eji.202250302 (2023).","journal-title":"Eur. J. Immunol."},{"key":"16097_CR20","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.lfs.2018.03.014","volume":"200","author":"S Fasolato","year":"2018","unstructured":"Fasolato, S. et al. SerpinB3 induces dipeptidyl-peptidase IV\/CD26 expression and its metabolic effects in hepatocellular carcinoma. Life Sci. 200, 134\u2013141. https:\/\/doi.org\/10.1016\/j.lfs.2018.03.014 (2018).","journal-title":"Life Sci."},{"issue":"2","key":"16097_CR21","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1078\/0171-9335-00302","volume":"82","author":"E Boonacker","year":"2003","unstructured":"Boonacker, E. & Van Noorden, C. J. F. The multifunctional or moonlighting protein CD26\/DPPIV. Eur. J. Cell. Biol. 82 (2), 53\u201373. https:\/\/doi.org\/10.1078\/0171-9335-00302 (2003).","journal-title":"Eur. J. Cell. Biol."},{"issue":"14","key":"16097_CR22","doi-asserted-by":"publisher","first-page":"4498","DOI":"10.3390\/molecules27144498","volume":"27","author":"X Hu","year":"2022","unstructured":"Hu, X., Wang, X. & Xue, X. Therapeutic perspectives of CD26 inhibitors in imune-mediated diseases. Mol. Basel Switz. 27 (14), 4498. https:\/\/doi.org\/10.3390\/molecules27144498 (2022).","journal-title":"Mol. Basel Switz."},{"issue":"1","key":"16097_CR23","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1038\/s41598-020-57935-6","volume":"10","author":"M Kawakubo","year":"2020","unstructured":"Kawakubo, M. et al. Dipeptidyl peptidase-4 inhibition prevents nonalcoholic steatohepatitis-associated liver fibrosis and tumor development in mice independently of its anti-diabetic effects. Sci. Rep. 10 (1), 983. https:\/\/doi.org\/10.1038\/s41598-020-57935-6 (2020).","journal-title":"Sci. Rep."},{"issue":"12","key":"16097_CR24","doi-asserted-by":"publisher","first-page":"342","DOI":"10.31083\/j.fbl2812342","volume":"28","author":"L Li","year":"2023","unstructured":"Li, L. et al. DPP4 regulates the Th17\/IL-17 axis and accelerates epithelial mesenchymal transition to promote ovalbumin-induced asthma in female C57BL\/6J mice. Front. Biosci. Landmark Ed. 28 (12), 342. https:\/\/doi.org\/10.31083\/j.fbl2812342 (2023).","journal-title":"Front. Biosci. Landmark Ed."},{"issue":"6","key":"16097_CR25","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.jacbts.2021.04.006","volume":"6","author":"Y Shiheido-Watanabe","year":"2021","unstructured":"Shiheido-Watanabe, Y. et al. A Xanthine-based dipeptidyl peptidase-4 inhibitor, ameliorates experimental autoimmune myocarditis. JACC Basic. Transl Sci. 6 (6), 527\u2013542. https:\/\/doi.org\/10.1016\/j.jacbts.2021.04.006 (2021).","journal-title":"JACC Basic. Transl Sci."},{"issue":"12","key":"16097_CR26","doi-asserted-by":"publisher","first-page":"2999","DOI":"10.2337\/dc20-1521","volume":"43","author":"SB Solerte","year":"2020","unstructured":"Solerte, S. B. et al. Sitagliptin treatment at the time of hospitalization was associated with reduced mortality in patients with type 2 diabetes and COVID-19: a multicenter, case-control, retrospective, observational study. Diabetes Care. 43 (12), 2999\u20133006. https:\/\/doi.org\/10.2337\/dc20-1521 (2020).","journal-title":"Diabetes Care"},{"key":"16097_CR27","doi-asserted-by":"publisher","first-page":"382","DOI":"10.3389\/fped.2019.00382","volume":"7","author":"M Sciveres","year":"2019","unstructured":"Sciveres, M., Nastasio, S. & Maggiore, G. Novel diagnostic and therapeutic strategies in juvenile autoimmune hepatitis. Front. Pediatr. 7, 382. https:\/\/doi.org\/10.3389\/fped.2019.00382 (2019).","journal-title":"Front. Pediatr."},{"issue":"4","key":"16097_CR28","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1016\/j.kint.2017.03.036","volume":"92","author":"JA Juno","year":"2017","unstructured":"Juno, J. A. et al. \u03b3\u03b4 T-cell function is inhibited in end-stage renal disease and impacted by latent tuberculosis infection. Kidney Int. 92 (4), 1003\u20131014. https:\/\/doi.org\/10.1016\/j.kint.2017.03.036 (2017).","journal-title":"Kidney Int."},{"issue":"10","key":"16097_CR29","doi-asserted-by":"publisher","first-page":"2476","DOI":"10.1002\/art.39732","volume":"68","author":"A Reinhardt","year":"2016","unstructured":"Reinhardt, A. et al. Interleukin-23-dependent \u03b3\/\u03b4 T cells produce interleukin-17 and accumulate in the enthesis, aortic valve, and ciliary body in mice. Arthritis Rheumatol. Hoboken NJ. 68 (10), 2476\u20132486. https:\/\/doi.org\/10.1002\/art.39732 (2016).","journal-title":"Arthritis Rheumatol. Hoboken NJ"},{"issue":"5734","key":"16097_CR30","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1126\/science.1114016","volume":"309","author":"BD Lindenbach","year":"2005","unstructured":"Lindenbach, B. D. et al. Complete replication of hepatitis C virus in cell culture. Science 309 (5734), 623\u2013626. https:\/\/doi.org\/10.1126\/science.1114016 (2005).","journal-title":"Science"},{"issue":"6","key":"16097_CR31","doi-asserted-by":"publisher","first-page":"2234","DOI":"10.2353\/ajpath.2009.081084","volume":"174","author":"C Klemann","year":"2009","unstructured":"Klemann, C. et al. Synthetic retinoid AM80 inhibits Th17 cells and ameliorates experimental autoimmune encephalomyelitis. Am. J. Pathol. 174 (6), 2234\u20132245. https:\/\/doi.org\/10.2353\/ajpath.2009.081084 (2009).","journal-title":"Am. J. Pathol."},{"issue":"6","key":"16097_CR32","doi-asserted-by":"publisher","first-page":"F718","DOI":"10.1152\/ajprenal.00372.2013","volume":"307","author":"S Rong","year":"2014","unstructured":"Rong, S. et al. Renal PKC-\u03b5 deficiency attenuates acute kidney injury and ischemic allograft injury via TNF-\u03b1-dependent Inhibition of apoptosis and inflammation. Am. J. Physiol. Ren. Physiol. 307 (6), F718\u2013726. https:\/\/doi.org\/10.1152\/ajprenal.00372.2013 (2014).","journal-title":"Am. J. Physiol. Ren. Physiol."},{"issue":"1","key":"16097_CR33","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1203\/01.PDR.0000130480.51066.FB","volume":"56","author":"CL Mack","year":"2004","unstructured":"Mack, C. L. et al. Biliary Atresia is associated with CD4\u2009+\u2009Th1 cell-mediated portal tract inflammation. Pediatr. Res. 56 (1), 79\u201387. https:\/\/doi.org\/10.1203\/01.PDR.0000130480.51066.FB (2004).","journal-title":"Pediatr. Res."},{"issue":"3","key":"16097_CR34","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1111\/cei.12757","volume":"184","author":"L Wagner","year":"2016","unstructured":"Wagner, L., Klemann, C., Stephan, M. & von H\u00f6rsten, S. Unravelling the immunological roles of dipeptidyl peptidase 4 (DPP4) activity and\/or structure homologue (DASH) proteins. Clin. Exp. Immunol. 184 (3), 265\u2013283. https:\/\/doi.org\/10.1111\/cei.12757 (2016).","journal-title":"Clin. Exp. Immunol."},{"issue":"10","key":"16097_CR35","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.3390\/biom11101446","volume":"11","author":"OJ Cordero","year":"2021","unstructured":"Cordero, O. J. et al. Distinctive CD26 expression on CD4 T-cell subsets. Biomolecules 11 (10), 1446. https:\/\/doi.org\/10.3390\/biom11101446 (2021).","journal-title":"Biomolecules"},{"issue":"7","key":"16097_CR36","doi-asserted-by":"publisher","first-page":"e0131992","DOI":"10.1371\/journal.pone.0131992","volume":"10","author":"OJ Cordero","year":"2015","unstructured":"Cordero, O. J. et al. CD26 expression on T helper populations and sCD26 serum levels in patients with rheumatoid arthritis. PloS One. 10 (7), e0131992. https:\/\/doi.org\/10.1371\/journal.pone.0131992 (2015).","journal-title":"PloS One"},{"issue":"1","key":"16097_CR37","doi-asserted-by":"publisher","first-page":"7556","DOI":"10.1038\/s41598-019-43622-8","volume":"9","author":"JJ Nieto-Fontarigo","year":"2019","unstructured":"Nieto-Fontarigo, J. J. et al. Expansion of different subpopulations of CD26-\/low T cells in allergic and non-allergic asthmatics. Sci. Rep. 9 (1), 7556. https:\/\/doi.org\/10.1038\/s41598-019-43622-8 (2019).","journal-title":"Sci. Rep."},{"issue":"7","key":"16097_CR38","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.1002\/eji.200939222","volume":"39","author":"DL Gibbons","year":"2009","unstructured":"Gibbons, D. L. et al. Neonates harbour highly active \u03b3\u03b4 T cells with selective impairments in preterm infants. Eur. J. Immunol. 39 (7), 1794\u20131806. https:\/\/doi.org\/10.1002\/eji.200939222 (2009).","journal-title":"Eur. J. Immunol."},{"key":"16097_CR39","doi-asserted-by":"publisher","first-page":"121648","DOI":"10.1016\/j.lfs.2023.121648","volume":"323","author":"MT Fontes","year":"2023","unstructured":"Fontes, M. T. et al. Dipeptidyl peptidase 4 inhibition rescues PKA-eNOS signaling and suppresses aortic hypercontractility in male rats with heart failure. Life Sci. 323, 121648. https:\/\/doi.org\/10.1016\/j.lfs.2023.121648 (2023).","journal-title":"Life Sci."},{"issue":"2","key":"16097_CR40","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1124\/dmd.116.073866","volume":"45","author":"M Asakura","year":"2017","unstructured":"Asakura, M. et al. Hepatic dipeptidyl peptidase-4 controls pharmacokinetics of vildagliptin in vivo. Drug Metab. Dispos. Biol. Fate Chem. 45 (2), 237\u2013245. https:\/\/doi.org\/10.1124\/dmd.116.073866 (2017).","journal-title":"Drug Metab. Dispos. Biol. Fate Chem."},{"key":"16097_CR41","doi-asserted-by":"publisher","unstructured":"Gao, X. et al. DPP4 is a potential prognostic marker of thyroid carcinoma and a target for immunotherapy. Prodam F, ed. Int J Endocrinol. ;2022:1\u201311. (2022). https:\/\/doi.org\/10.1155\/2022\/5181386","DOI":"10.1155\/2022\/5181386"},{"issue":"3","key":"16097_CR42","doi-asserted-by":"publisher","first-page":"41","DOI":"10.3892\/ijo.2023.5489","volume":"62","author":"J Du","year":"2023","unstructured":"Du, J. et al. Effect of DPP4\/CD26 expression on SARS\u2013CoV\u20132 susceptibility, immune response, adenosine (derivatives m 6 2 A and CD) regulations on patients with cancer and healthy individuals. Int. J. Oncol. 62 (3), 41. https:\/\/doi.org\/10.3892\/ijo.2023.5489 (2023).","journal-title":"Int. J. Oncol."},{"issue":"3","key":"16097_CR43","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1046\/j.1365-3083.2001.00984.x","volume":"54","author":"MD Gorrell","year":"2001","unstructured":"Gorrell, M. D., Gysbers, V. & McCaughan, G. W. CD26: a multifunctional integral membrane and secreted protein of activated lymphocytes. Scand. J. Immunol. 54 (3), 249\u2013264. https:\/\/doi.org\/10.1046\/j.1365-3083.2001.00984.x (2001).","journal-title":"Scand. J. Immunol."},{"issue":"11","key":"16097_CR44","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1007\/s00262-009-0728-1","volume":"58","author":"OJ Cordero","year":"2009","unstructured":"Cordero, O. J., Salgado, F. J. & Nogueira, M. On the origin of serum CD26 and its altered concentration in cancer patients. Cancer Immunol. Immunother CII. 58 (11), 1723\u20131747. https:\/\/doi.org\/10.1007\/s00262-009-0728-1 (2009).","journal-title":"Cancer Immunol. Immunother CII"},{"issue":"1","key":"16097_CR45","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/s0022-2143(99)90054-9","volume":"134","author":"F Perner","year":"1999","unstructured":"Perner, F. et al. Dipeptidyl peptidase activity of CD26 in serum and urine as a marker of cholestasis: experimental and clinical evidence. J. Lab. Clin. Med. 134 (1), 56\u201367. https:\/\/doi.org\/10.1016\/s0022-2143(99)90054-9 (1999).","journal-title":"J. Lab. Clin. Med."},{"issue":"8953","key":"16097_CR46","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1016\/s0140-6736(95)93003-5","volume":"345","author":"G R\u00e1koczi","year":"1995","unstructured":"R\u00e1koczi, G. et al. Increased urinary dipeptidyl peptidase IV activity in extrahepatic biliary Atresia. Lancet Lond. Engl. 345 (8953), 864\u2013865. https:\/\/doi.org\/10.1016\/s0140-6736(95)93003-5 (1995).","journal-title":"Lancet Lond. Engl."},{"issue":"4","key":"16097_CR47","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/S1665-2681(19)31905-2","volume":"6","author":"YH Balaban","year":"2007","unstructured":"Balaban, Y. H. et al. Dipeptidyl peptidase IV (DDP IV) in NASH patients. Ann. Hepatol. 6 (4), 242\u2013250 (2007).","journal-title":"Ann. Hepatol."},{"issue":"1","key":"16097_CR48","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.jcmgh.2018.08.008","volume":"7","author":"S Nishina","year":"2019","unstructured":"Nishina, S. et al. Dipeptidyl peptidase 4 inhibitors reduce hepatocellular carcinoma by activating lymphocyte chemotaxis in mice. Cell. Mol. Gastroenterol. Hepatol. 7 (1), 115\u2013134. https:\/\/doi.org\/10.1016\/j.jcmgh.2018.08.008 (2019).","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"issue":"2","key":"16097_CR49","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1007\/s10753-018-00954-3","volume":"42","author":"MR Davanso","year":"2019","unstructured":"Davanso, M. R. et al. DPP-4 inhibition leads to decreased pancreatic inflammatory profile and increased frequency of regulatory T cells in experimental type 1 diabetes. Inflammation 42 (2), 449\u2013462. https:\/\/doi.org\/10.1007\/s10753-018-00954-3 (2019).","journal-title":"Inflammation"},{"issue":"21","key":"16097_CR50","doi-asserted-by":"publisher","first-page":"5495","DOI":"10.3390\/cancers13215495","volume":"13","author":"JM Henderson","year":"2021","unstructured":"Henderson, J. M. et al. Dipeptidyl peptidase inhibition enhances CD8 T cell recruitment and activates intrahepatic inflammasome in a murine model of hepatocellular carcinoma. Cancers 13 (21), 5495. https:\/\/doi.org\/10.3390\/cancers13215495 (2021).","journal-title":"Cancers"},{"key":"16097_CR51","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.ejps.2016.12.040","volume":"100","author":"MM Pinheiro","year":"2017","unstructured":"Pinheiro, M. M. et al. Sitagliptin inhibit human lymphocytes proliferation and Th1\/Th17 differentiation in vitro. Eur. J. Pharm. Sci. Off J. Eur. Fed. Pharm. Sci. 100, 17\u201324. https:\/\/doi.org\/10.1016\/j.ejps.2016.12.040 (2017).","journal-title":"Eur. J. Pharm. Sci. Off J. Eur. Fed. Pharm. Sci."},{"issue":"2","key":"16097_CR52","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1089\/ars.2016.6953","volume":"28","author":"X Wang","year":"2018","unstructured":"Wang, X. et al. Gliptins suppress inflammatory macrophage activation to mitigate inflammation, fibrosis, oxidative stress, and vascular dysfunction in models of nonalcoholic steatohepatitis and liver fibrosis. Antioxid. Redox Signal. 28 (2), 87\u2013109. https:\/\/doi.org\/10.1089\/ars.2016.6953 (2018).","journal-title":"Antioxid. Redox Signal."},{"issue":"5","key":"16097_CR53","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1038\/icb.2016.116","volume":"95","author":"XM Wang","year":"2017","unstructured":"Wang, X. M. et al. The pro-fibrotic role of dipeptidyl peptidase 4 in carbon tetrachloride\u2010induced experimental liver injury. Immunol. Cell. Biol. 95 (5), 443\u2013453. https:\/\/doi.org\/10.1038\/icb.2016.116 (2017).","journal-title":"Immunol. Cell. Biol."},{"key":"16097_CR54","doi-asserted-by":"publisher","first-page":"6","DOI":"10.21037\/jlpm-20-93","volume":"6","author":"G Ndrepepa","year":"2021","unstructured":"Ndrepepa, G. Aspartate aminotransferase and cardiovascular disease\u2014a narrative review. J. Lab. Precis Med. 6, 6\u20136. https:\/\/doi.org\/10.21037\/jlpm-20-93 (2021).","journal-title":"J. Lab. Precis Med."},{"issue":"5","key":"16097_CR55","doi-asserted-by":"publisher","first-page":"L834","DOI":"10.1152\/ajplung.00031.2018","volume":"315","author":"T Kawasaki","year":"2018","unstructured":"Kawasaki, T., Chen, W., Htwe, Y. M., Tatsumi, K. & Dudek, S. M. DPP4 inhibition by sitagliptin attenuates LPS-induced lung injury in mice. Am. J. Physiol-Lung Cell. Mol. Physiol. 315 (5), L834\u2013L845. https:\/\/doi.org\/10.1152\/ajplung.00031.2018 (2018).","journal-title":"Am. J. Physiol-Lung Cell. Mol. Physiol."},{"issue":"8","key":"16097_CR56","doi-asserted-by":"publisher","first-page":"e104873","DOI":"10.1371\/journal.pone.0104873","volume":"9","author":"A Mondragon","year":"2014","unstructured":"Mondragon, A. et al. Divergent effects of liraglutide, exendin-4, and sitagliptin on beta-cell mass and indicators of pancreatitis in a mouse model of hyperglycaemia. PloS One. 9 (8), e104873. https:\/\/doi.org\/10.1371\/journal.pone.0104873 (2014).","journal-title":"PloS One"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-16097-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-16097-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-16097-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T05:12:44Z","timestamp":1757394764000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-16097-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,18]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["16097"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-16097-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"type":"electronic","value":"2045-2322"}],"subject":[],"published":{"date-parts":[[2025,8,18]]},"assertion":[{"value":"23 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"30226"}}